| Date | Title | Description | Source |
| 03.04.2024 | Diagonal launches with $128M and a platform slanted toward a... | Diagonal Therapeutics is taking shape, launching with $128 million and backed by the likes of BVF Pa... | fiercebiot... |
| 27.03.2024 | Unable to find a partner for stem cell therapy, Gamida accep... | With the search for a partner for an approved stem cell therapy coming up short, cash-strapped Gamid... | fiercebiot... |
| 25.03.2024 | Tonix Pharmaceuticals Receives Rare Pediatric Disease Design... | TNX-2900 is a proprietary magnesium-potentiated formulation of intranasal oxytocin, a naturally occu... | einpresswi... |
| 15.03.2024 | Health | Why COVID patients who could most benefit from Paxl... | Arthur Allen | KFF Health News (TNS)
Evangelical minister Eddie Hyatt believes in the healing power ... | dailycamer... |
| 29.02.2024 | With seeds from Turning Point, a new biotech blooms with $10... | The first signs of spring are beginning to emerge and so too are the shoots of the next biotech from... | fiercebiot... |
| 23.02.2024 | The Triangle's biotech growth has skyrocketed in the past de... | Data: CBRE; Chart: Axios Visuals
In less than a decade, the Triangle's biotech industry has more tha... | axios.com/... |
| 22.02.2024 | Frontier CEO weathers 'one of the hardest financings' of his... | Frontier Medicines has just closed a $80 million fundraising, but, according to CEO Chris Varma, Ph.... | fiercebiot... |
| 21.02.2024 | It’s a mistake to assume Elon Musk is lying all the time—but... | So, what to make of that Elon Musk comment earlier this week about Neuralink’s first patient seeming... | fortune.co... |
| 13.02.2024 | Capitalizing on ADC frenzy, ProfoundBio attracts $112M overs... | With Big Pharmas heading into 2024 with a renewed interest in antibody-drug conjugates (ADCs), it’s ... | fiercebiot... |
| 29.01.2024 | 23andMe breach targeted Chinese, Jewish populations | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
| 19.01.2024 | The Senate health committee looks into its first subpoena in... | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
| 16.01.2024 | The four biotech stories you need to read this morning | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
| 09.01.2024 | JPM24, Day 2: GSK, Eli Lilly, Blueprint, SR One and more | Welcome to Day 2 of the J.P. Morgan Healthcare Conference 2024 in San Francisco. Yesterday "Mer... | fiercebiot... |
| 08.01.2024 | Biopharma M&A ripens as JPM launches | The JPMorgan Health Care Conference — the definitive launchpad for industry dealmaking — kicked off ... | axios.com/... |
| 08.01.2024 | JPM24 opens with ADCs the hottest ticket in San Francisco | The overall deal flow in biopharma tapered off in 2023 but the big companies sure know what they wan... | fiercebiot... |
| 29.12.2023 | There’s a less intimidating alternative to EpiPens for dange... | My son Thomas has carried around a needle since he entered kindergarten at the age of 5. That was a ... | statnews.c... |
| 27.12.2023 | Editor's Corner: Fierce Biotech's top 10 editor's picks for ... | The Fierce Biotech team has been all over the place this year: Copenhagen, Madrid, London, New York,... | fiercebiot... |
| 18.12.2023 | Alzheimer’s drug approvals show we need a reevaluation of pa... | When faced with a loved one’s progressive neurodegenerative disease, like Alzheimer’s, or your child... | statnews.c... |
| 18.12.2023 | Biotechs end year 'trading for nothing' as investors mull 'w... | “It's been, I would say, probably one of the more challenging years of my professional career.” So s... | fiercebiot... |
| 08.12.2023 | CORRECTION: Newsletter December 2023 – Summing up the year w... | CORRECTION: Newsletter December 2023 – Summing up the year with a Christmas message and Cline’s brig... | news.cisio... |
| 08.12.2023 | Intrigued by Novartis and Lilly deals, investors pour money ... | All of a sudden, radiopharmaceuticals are the hottest game in town—outside of antibody drug conjugat... | fiercebiot... |
| 07.12.2023 | Diabetes ‘epidemic’ gets a Senate hearing | You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics ... | statnews.c... |
| 07.12.2023 | Newsletter December 2023 – Summing up the year with a Christ... | Newsletter December 2023 – Summing up the year with a Christmas message and Cline’s bright view of t... | news.cisio... |
| 04.12.2023 | Novartis is building a new radioligand plant in China | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
| 20.11.2023 | Merck cough drug doesn’t pass panel scrutiny | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
| 20.11.2023 | The Disconnect between R&D Costs and High Drug Prices | In the U.S., we pay approximately 2.5 times more than people in other countries. This matters, and i... | medcitynew... |
| 20.11.2023 | Fosun, Treehill launch joint investment business to fund dru... | A new collaboration between Fosun Pharma’s U.S. branch and consulting firm Treehill Partners will pr... | fiercebiot... |
| 14.11.2023 | Russell Wilson and Ciara: How the Broncos quarterback and R&... | Entertainment Russell Wilson and Ciara: How the Broncos quarterback and R&B artist make and spen... | businessin... |
| 02.11.2023 | Do celebrity vaccine endorsements like Travis Kelce’s actual... | Once the domain of aging TV stars, hawking health products from vitamins to diabetes supplies to a g... | statnews.c... |
| 31.10.2023 | Health | Analysis: A new era of vaccines leaves old question... | Elisabeth Rosenthal | (TNS) KFF Health News
The world is entering a new era of vaccines. Following t... | dailycamer... |
| 14.10.2023 | Inflation Reduction Act’s Drug Pricing Provisions May Lead T... | The high price of cancer drugs has led to usage of the term "financial toxicity" to descri... | forbes.com... |
| 09.10.2023 | After pandemic sugar rush, a market 'hangover' opens biotech... | You're not going to hear a private biotech trumpeting a down round as they announce a new batch of f... | fiercebiot... |
| 06.10.2023 | Flush with Wegovy cash, Novo Nordisk's owner widens investme... | Outside of a global pandemic, it’s rare for a medicine to truly become a household name. But Novo No... | fiercebiot... |
| 05.10.2023 | Ketamine-Based Nasal Spray Can Be a Better Option for Patien... | Joseph Henry, Tech Times 05 October 2023, 12:10 pm
(Photo: Kelly Sikkema from Unsplash) Taking ketam... | techtimes.... |
| 22.09.2023 | Health | Save billions or stick with Humira? Drug brokers st... | Arthur Allen | (TNS) KFF Health News
Tennessee last year spent $48 million on a single drug, Humira ... | dailycamer... |
| 13.09.2023 | Sanofi, Ice-T Unveil Horror-Themed Flu Warning Campaign to E... | John Lopez, Tech Times 13 September 2023, 02:09 pm
Global healthcare company Sanofi has joined force... | techtimes.... |
| 06.09.2023 | Politicians Are At War With The Pharma Industry. And Patient... | WASHINGTON DC, UNITED STATES - AUGUST 29: US President Joe Biden speaks during an event celebrating ... | forbes.com... |
| 05.09.2023 | Kim Kardashian’s Promotion Of Full-Body Scans Raises Questio... | HOLLYWOOD, CALIFORNIA: Kim Kardashian speaks onstage during the 2nd Annual American Influencer ... [... | forbes.com... |
| 01.09.2023 | Digital therapeutics could help with your insomnia, depressi... | About 40 digital-therapeutic apps have been cleared by the Food and Drug Administration since 2017. ... | businessin... |
| 29.08.2023 | FDA Approves Vyvanse Generics Amid ADHD Medication Shortage | The Food and Drug Administration on Monday announced it had approved generic versions of Vyvanse, an... | forbes.com... |
| 22.08.2023 | Business | California drug company ImmunityBio cuts jobs at ... | LOUISVILLE — ImmunityBio Inc. (Nasdaq: IBRX), a struggling California-based drug company that develo... | dailycamer... |
| 08.08.2023 | Impact of new pill to treat postpartum depression will depen... | The approval of the first-ever pill treating postpartum depression on Friday was hailed as a signifi... | axios.com/... |
| 18.07.2023 | The two-horse race to make blockbuster obesity drugs | The push to develop blockbuster weight loss drugs has turned into a two-horse race between Novo Nord... | axios.com/... |
| 06.07.2023 | Low-cost Humira competitors hit the U.S. market | Several biosimilars for Abbvie's blockbuster rheumatoid arthritis drug Humira officially hit the U.S... | axios.com/... |
| 05.07.2023 | Pfizer, AstraZeneca, and Moderna stocks lost $67 billion in ... | Over the past three months, some of the world’s biggest pharmaceutical companies, including Pfizer (... | finbold.co... |
| 01.07.2023 | BioMarin’s Next Roctavian Challenge Is How To Successfully C... | This photo provided by BioMarin in June 2023 shows a vial and packaging for their gene therapy, ... ... | forbes.com... |
| 28.06.2023 | Can A Woman Be Respected If She’s In The Same Industry As He... | Alex Denner is an activist investor. As the head of Sarissa Capital Management, he has been quite su... | forbes.com... |
| 22.06.2023 | Emerging Investment Opportunities In Diabetes Treatment | Luis Berruga is the CEO of Global X ETFs. | forbes.com... |
| 21.06.2023 | Sanofi Goes All-In On AI | Chief Executive Officer of French pharmaceutical giant Sanofi, Paul Hudson, Paris, September 8, ... ... | forbes.com... |
| 21.06.2023 | CDC advisory panel recommends seniors ‘may’ get RSV vaccine... | A panel of experts that advises the Centers for Disease Control and Prevention on vaccinations opted... | statnews.c... |
| 10.06.2023 | Neurologist Dr. Mateja de Leonni Stanonik provides update on... | Dr. Mateja de Leonni Stanonik, Vita Medica Institute, Tucson, Arizona
Dr. Mateja de Leonni Stanonik,... | einpresswi... |
| 30.05.2023 | The End of One Health Crisis Must Not Lead to a New One | Paula LeClair, U.S. General Manager of Healthy.io
Three years after the World Health Organization de... | hitconsult... |
| 16.05.2023 | AstraZeneca is third member to leave PhRMA in five months | WASHINGTON — AstraZeneca has decided to leave the brand drug lobbying powerhouse PhRMA halfway throu... | statnews.c... |
| 03.05.2023 | Gene Therapies Are Still Hampered By Substantial Delays Betw... | Editing gene biology and reproductive genetic biotechnology as a 3D illustration.getty | forbes.com... |
| 02.05.2023 | ICER’s Positive Cost-Effectiveness Assessment Lends Support ... | Dr. Steven D. Pearson, the president of the Institute for Clinical and Economic Review (ICER) poses ... | forbes.com... |
| 10.04.2023 | 3 reasons digital-healthcare pioneer Hims is staying out of ... | Andrew Dudum, a cofounder and the CEO of Hims & Hers. Hims This story is available exclusively t... | businessin... |
| 10.04.2023 | Don't Let Progressives Assign A Dollar Value To Human Life | WASHINGTON, DC - MARCH 23: Representative Cathy McMorris Rodgers (R-WA), chair of the House Energy .... | forbes.com... |
| 30.03.2023 | To deal with the next pandemic, the FDA needs an Office of P... | New evidence of the spillover of the avian flu virus, known as H5N1, to some mammals is again raisin... | statnews.c... |
| 29.03.2023 | J&J Portfolio Review Culls RSV Vaccine, Ending the Phase... | Respiratory syncytial virus vaccines could be approved and ready for arms by next fall, but a Johnso... | medcitynew... |
| 26.03.2023 | Five First Steps For Addressing Workplace Ageism | | forbes.com... |
| 22.03.2023 | The much-maligned ‘quality-adjusted life year’ is a vital to... | Health policy circles have erupted in debate over a wonky administrative tool: the quality-adjusted ... | statnews.c... |
| 17.03.2023 | What to know about Mounjaro, the next game-changing medicati... | Health What to know about Mounjaro, the next game-changing medication awaiting FDA approval to treat... | businessin... |
| 13.03.2023 | Why buzzy weight-loss drugs are the next craze for healthcar... | This story is available exclusively to Insider subscribers. Become an Insider and start reading now.... | businessin... |
| 06.03.2023 | Workers are clamoring for pricey new weight-loss drugs like ... | Crystal Cox/Business Insider This story is available exclusively to Insider subscribers. Become an I... | businessin... |
| 03.03.2023 | Big Pharma regained 'mojo' last year, but biotech valuations... | Anyone looking for a road map out of the biotech bear market will take little comfort from Evaluate ... | fiercebiot... |
| 23.02.2023 | ‘A slippery slope’: A looming nationwide abortion pill ban c... | Soon after the Supreme Court overturned Roe v. Wade, a former Republican congressman made what might... | statnews.c... |
| 14.02.2023 | Doing More with Moore: Biotech’s Tech Moment | Eroom’s Law (the backwards Moore) is the often cited, and arguably inaccurate, observation that drug... | a16z.com/2... |
| 03.02.2023 | Health
Health | 325,000 Coloradans will lose Medicaid. Vacc... | Starting in April, Colorado will see the largest shift in how people get their health insurance sinc... | dailycamer... |
| 03.02.2023 | Some American employers are adding jobs like gangbusters. He... | The economy may be showing signs of weakness, with consumer spending wobbling and home purchases sin... | cbsnews.co... |
| 02.02.2023 | Rare polio case highlights how hard it will be to keep polio... | An incident that took place at a Dutch polio vaccine production facility late last year is a critica... | statnews.c... |
| 18.01.2023 | I prescribe the popular weight-loss drug semaglutide to my p... | Dr. Paul Kolodzik thinks semaglutide may be the most widely prescribed medicine in the history of th... | businessin... |
| 16.01.2023 | Novartis' CEO is charging ahead in cutting tens of thousands... | Vasant Narasimhan, the CEO of Novartis. Novartis This story is available exclusively to Insider subs... | businessin... |
| 13.01.2023 | Here are 5 winners and 4 losers from the healthcare industry... | Westend61/Getty Images This story is available exclusively to Insider subscribers. Become an Insider... | businessin... |
| 12.01.2023 | Sanofi CEO: We Don’t Have a Leaky Bathtub | Deal announcements are in the very DNA of the annual biotech wind-blown event also known as the J.P.... | medcitynew... |
| 06.01.2023 | Inflation, Recession And Marketing Technology: Four Strategi... | CMO at PwC U.S. and an innovative executive at the crossroads of marketing, media and technology. | forbes.com... |
| 04.01.2023 | Biotech investor Brad Loncar shares 10 predictions for 2023,... | Brad Loncar, biotech investor and CEO of Loncar Investments Brad Loncar This story is available excl... | businessin... |
| 21.12.2022 | Interim Report 2 2022/23 | Interim Report 2 2022/23
Wed, Dec 21, 2022 09:09 CET Report this content
AUGUST – OCTOBER
Net sales ... | news.cisio... |
| 21.12.2022 | The US is releasing doses of flu medicine from the national ... | tommaso79/Getty Images
HHS said today that states can now access the national stockpile of Tamiflu, ... | businessin... |
| 15.12.2022 | 2023 Likely To Be a Crucial Year for Pharma—and Insurers | Change is in the air, and people can sense it; the recent midterm elections saw one of the biggest t... | medcitynew... |
| 07.12.2022 | Healthcare Data Leader H1 Releases Its Top Predictions for 2... | Which data will inform more diverse clinical trials? Will healthcare influencers leave Twitter? How ... | einpresswi... |
| 05.12.2022 | The most expensive drug in the world has a $3.5 million pric... | Bryen Lackey, 18, has the genetic bleeding disorder hemophilia B. He said he could be interested in ... | businessin... |
| 24.11.2022 | Sarah McDonald from Baymatob named one of 2022’s Fiercest Wo... | Congratulations to Sarah McDonald, the inspirational founder of medtech company Baymatob, for being ... | alberts.co... |
| 24.10.2022 | Why Good Research Doesn’t Need To Take A Long Time | Founder & COO of DNA Script, pioneering a new, fast, powerful and versatile way to design and ma... | forbes.com... |
| 24.10.2022 | Meeting the needs of rare disease patients: Improved access ... | Anyone who steps into the shoes of a person with a rare disease will experience not only the dishear... | medcitynew... |
| 24.10.2022 | Digital health news, funding round up in the prior week; Oct... | Eli Lilly acquired Akouos; Tempus raised $275M; Calm launched Calm Health
Top Health News
Pfizer ask... | vator.tv/n... |
| 19.10.2022 | Oops, we forgot to fix the supply chain | At first glance, it might look like the pandemic-era supply chain chaos is nearly over.
Headlines be... | vox.com/re... |
| 06.10.2022 | With FDA decision one month away, Provention partners wi... | Though its FDA decision is one month away, Provention Bio has already begun its commercial ef... | endpts.com... |
| 03.10.2022 | See the 11-slide pitch deck that Lyfegen used to win over in... | Lyfegen CEO Girisha Fernando. Lyfegen This story is available exclusively to Insider subscribers. Be... | businessin... |
| 22.09.2022 | Embattled CEO Werner Baumann enters his final chapter at Bay... | Werner Baumann, the CEO of Bayer AG. Wolfgang Rattay/Reuters This story is available exclusively to ... | businessin... |
| 19.09.2022 | Questex Continues Award Winning Streak, Wins Five Folio: Edd... | /EIN News/ -- NEW YORK, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Questex, a leading information services a... | einpresswi... |
| 08.09.2022 | VC firm LifeArc sells first portfolio company as dermatitis-... | LifeArc Ventures’ billion-pound investment strategy appears to be paying off, as the British life sc... | fiercebiot... |
| 29.08.2022 | Novartis to shutter NC-based Sandoz plant ahead of spin... | As Sandoz is ready to spin out from Novartis, the parent company is shuttering an oral soli... | endpts.com... |
| 26.08.2022 | Moderna подала в суд на Pfizer и BioNTech из-за вероятного н... | Фармацевтическая и биотехнологическая компания Moderna подала в суд на Pfizer и BioNTech из-за предп... | habr.com/r... |
| 25.08.2022 | Aktis makes waves with $84M extension as 3 big pharmas chann... | Aktis Oncology has closed a series A extension round to the tune of $84 million, with big pharmas Me... | fiercebiot... |
| 25.08.2022 | In the current venture climate, tech for pharma is recession... | Among the world’s top 20 pharmaceutical companies, ranked according to their 2021 revenue, 19 genera... | medcitynew... |
| 19.08.2022 | miR Scientific lights up landmarks in blue for prostate ... | A year ago, miR Scientific lit up La Fortaleza, the governor’s mansion in Puerto Rico, and... | endpts.com... |
| 04.08.2022 | The outsized effect of ‘modest’ price controls on pharmaceut... | Drug price controls in the U.S. Senate are being met with dire warnings that such an approach will s... | statnews.c... |
| 28.07.2022 | Manufacturing roundup: GenBioPro looks to counter Mis... | As the issues from the Roe V. Wade decision continue to cascade in various circles, includ... | endpts.com... |
| 25.07.2022 | VC firms, biotechs push back on drug pricing bill that would... | Some of the leading biotech investment firms say the senate’s proposed drug pricing bill will render... | fiercebiot... |
| 13.07.2022 | Areteia Therapeutics Raises $350M To Create An Oral Asthma T... | 2 Shares Email Facebook Twitter LinkedIn
The first oral drug for eosinophilic asthma patients may be... | news.crunc... |
